Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Fukuda, M

    1. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
      K Maeda and M Fukuda
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 765-769;

  2. Fukuyama, S

    1. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
      Y Kita, Y Hirasawa, S Fukuyama, K Ohkubo, Y Kato, H Takamatsu, M Ohno, S Nishino, M Kato and J Seki
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 421-425;

  3. Furukawa, Y

    1. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
      H Imamura, Y Furukawa, H Nakano, M Kasama, Y Hoyano and S Chiba
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 467-472;

  4. Galinsky, R E

    1. Effect of lipid-free total parenteral nutrition on hepatic drug conjugation in rats.
      R B Raftogianis, M R Franklin and R E Galinsky
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 602-608;

  5. Gargalidis-moudanos, C

    1. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
      I Limon-Boulez, F Tesson, C Gargalidis-Moudanos and A Parini
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 359-364;

  6. Gehrke, L J

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  7. Gerak, L R

    1. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
      L R Gerak and C P France
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 523-531;

  8. Giacomini, K M

    1. Saturable disposition of taurine in the rat cerebrospinal fluid.
      S J Chung, V K Ramanathan, C M Brett and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 676-682;

  9. Gillespie, T

    1. Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.
      B J Ring, J Catlow, T J Lindsay, T Gillespie, L K Roskos, B J Cerimele, S P Swanson, M A Hamman and S A Wrighton
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 658-666;

  10. Glennon, R A

    1. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
      R Young and R A Glennon
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 594-601;
« Previous (Pages : 6 7 8 9 10 11 12 13 14 15 ... 31) Next »
Back to top

In this issue

Advertisement